GBDTs are customarily used on non-image datasets that lack inherent symmetries, which might be why data symmetry in the context of GBDT classifiers has not received much attention. In this paper, we ...

Indian equity indices Sensex and Nifty50 fell sharply on Friday, with major declines in Infosys and Axis Bank shares post their Q3 results. Reliance Industries' shares rose following strong profit ...

Axis Bank shares: The lender reported a 3.8% increase in consolidated net profit for Q3 FY25. The net interest income grew by 9%, and operating profit rose 15%. Despite the positive outcomes, analysts ...

Mumbai: Axis Bank's struggles with asset quality continued in the third quarter (October-December) of the current financial year, slowing down loan growth and hurting profitability, as the private ...

Companies that will announce quarterly earnings on January 16 are Alokinds, Axis Bank, Bhansali Engineering Polymers, D B Corp, Decillion Finance, Digicontent, G G Automotive Gears, G G ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Whether this was done out of a sense of morality, ideology, or some reason known only to them, here are a few examples of when Axis and Allies worked together. More for You Trump pardons 1,500 ...

Get Wall Street's Hottest Chart Every Morning RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients who ...

THE rise of autonomous driving technology puts ride-hailing firms in a dilemma: Adopt the technology now at a high cost for an uncertain payout, or wait and see and risk losing market share. The ...

Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of $520.00. Discover outperforming stocks and invest ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

Axis Bank Ltd., one of India’s leading private sector lenders, informed the stock exchanges that it will release its financial results for the quarter ending Dec. 31, 2024, this week. With a market ...